PursueCare Blog

February 14, 2019

Study reveals increased restrictions on coverage of buprenorphine for Medicare Part D plans

Study reveals increased restrictions on coverage of buprenorphine for Medicare Part D plans By Dr. Jessica Badichek, PharmD A recent study published in JAMA, the Journal of the American Medical Association, summarized findings on the coverage of buprenorphine under Medicare Part D. Buprenorphine and buprenorphine combined with naloxone is one […]
January 29, 2019

FDA supports development of over-the-counter naloxone

  FDA supports development of over-the-counter naloxone By Dr. Jessica Badichek, PharmD A recent statement from FDA Commissioner Dr. Scott Gottlieb summarized the FDA’s new efforts in encouraging drug manufacturers to develop an over-the-counter version of naloxone, the opioid overdose treatment. The FDA stated that the number of overdose deaths […]
January 14, 2019

Drug Overdoses linked to Synthetic Opioids

  Drug Overdoses linked to Synthetic Opioids By Dr. Jessica Badichek, PharmD According to CDC analysis of the latest drug overdose death data, there were 63,632 drug overdose deaths in the United States in 2016. This was calculated as a 21.4% increase from 2015 data and the largest increase was […]
December 12, 2018
Woman sitting at laptop computer

Addiction Treatment & Telemedicine: An Update

  Addiction Treatment & Telemedicine: An Update By Dr. Jessica Badichek, PharmD The Centers for Medicare and Medicaid Services (CMS) recently published a report summarizing current evidence and practices in telemedicine-based services. This report discusses the substance abuse treatment barriers that persist throughout the country and how telemedicine also known […]
November 26, 2018
Remote medicine concept.

Treating the Epidemic, Part 3: The Future of Addiction Treatment

Treating the Epidemic, Part 3: The Future of Addiction Treatment With the rising need for qualified providers to work together in MAT programs to improve “whole person” OUD care outcomes, the federal government has given its support to the use of telemedicine to treat OUD, beginning with the initial assessment […]
November 19, 2018
Disruption

Treating the Epidemic, Part 2: The Dangers of Disruption

Treating the Epidemic, Part 2: The Dangers of Disruption In the first post of this series, we began looking at the problems with the existing system in place to treat the wide-spread issue of opiate addiction. Today we ask, with millions of Americans already addicted to opiates and trying to […]
November 12, 2018
Treating the Epidemic, Part 1: Problems From the Start

Treating the Epidemic, Part 1: Problems From the Start

Treating the Epidemic, Part 1: Problems From the Start In our national conversations about the opioid epidemic in America, much attention has been given to the various factors and mechanisms which influenced the development of this wide-spread problem. In this 3-part blog post series, Treating the Epidemic, we will stand […]
November 1, 2018
Chronic Pain and Non-Opioid Medications

Chronic Pain and Non-Opioid Medications

Chronic Pain and Non-Opioid Medications By Dr. Jessica Badichek, PharmD More than 25 million Americans suffer from daily chronic pain. Chronic pain has many types of treatments but all too often patients are prescribed opioid medications that are highly addictive. While opioid medications may be effective for acute and various […]
October 24, 2018
Addiction Treatment and Telemedicine

Addiction Treatment and Telemedicine

Addiction Treatment and Telemedicine By Dr. Jessica Badichek, PharmD The U.S. Department of Health & Human Services (HHS) recently published a document explaining how healthcare providers can use telemedicine as a tool in buprenorphine-based MAT (Medication-Assisted Treatment) for opioid use disorder. This document helps clarify how telemedicine may be used […]
September 28, 2018
Naloxone An Emergency Lifesaver

Naloxone: An Emergency Lifesaver

Naloxone: An Emergency Lifesaver By Dr. Jessica Badichek, PharmD Naloxone (brand name Narcan®) is the primary reversal agent for opioid overdoses. It is known as an “opioid antagonist”. This means that it blocks the opioid receptor sites in the body and reverses the toxic effects of opioid overdose. Opioid overdose […]